Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Massimo Martino

Director Stem Cell Transplant Program

Azienda ospedaliera "Bianchi-Melacrino-Morelli"

Research Interests

Explore related searches

Articles (20)

Collaborators (6)

Alessandro Allegra

University of Messina

Attilio Olivieri

Full Professor

Università Politecnica delle Marche

Michele Malagola

Docenti di ruolo di IIa fascia

University of Brescia

Simona Bernardi

assegnista di ricerca

University of Brescia

José Antonio Pérez-Simón

Universidad de Sevilla

Maria Paola Martelli

University of Perugia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimo Martino

Research Interests

Explore related searches

Articles (20)

Collaborators (6)

Alessandro Allegra

Attilio Olivieri

Michele Malagola

Simona Bernardi

José Antonio Pérez-Simón

Maria Paola Martelli

Make your next move.

Massimo Martino

Research Interests

Explore related searches

Articles (20)

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Complications Working Party (CWP)

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy

BCMA‐Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management

Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40–65 in first complete remission

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes

Outcomes of CAR T‐Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study

Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study

Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic Paradigms

Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timing

Quality of Life in CAR-T Cell Therapy

A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care

Efficacy of Polyvinylpyrrolidone–Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond

The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision Strategies

SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma

Collaborators (6)

Alessandro Allegra

Attilio Olivieri

Michele Malagola

Simona Bernardi

José Antonio Pérez-Simón

Maria Paola Martelli

Make your next move.